Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 694 Records) |
| Query Trace: Carcinoma and KRAS[original query] |
|---|
| Predictive Roles of ADAM17 in Patient Survival and Immune Cell Infiltration in Hepatocellular Carcinoma. International journal of molecular sciences 2023 12 24 (23): . Tianlong Ding, Yang Yu, Lei Gao, Lin Xiang, Bo Xu, Baohong Gu, Hao Ch |
| RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of Inverted Urothelial Papilloma of the Bladder. The American journal of surgical pathology 2023 12 . Keiichiro Kitahama, Yasuyuki Shigematsu, Gulanbar Amori, Emiko Sugawara, Junji Yonese, Junji Shibahara, Kengo Takeuchi, Kentaro Inamu |
| Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
| Concomitant Non-V600E BRAF and KRAS Mutations in Colorectal Carcinoma by Next-Generation Sequencing: A Distinct Subtype. International journal of surgical pathology 2023 12 10668969231215425. Pallavi Srivastava, Sridhar Mishra, Saumya Shukla, Pooja Sharma, Nuzhat Husa |
| Driver gene KRAS aggravates cancer-associated stroke outcomes. Thrombosis research 2023 11 233 55-68. Haomin Yan, Tsutomu Sasaki, Yasufumi Gon, Kumiko Nishiyama, Hideaki Kanki, Hideki Mochizu |
| Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. Cell reports. Medicine 2024 9 101711. Daowei Yang, Xinlei Sun, Rohan Moniruzzaman, Hua Wang, Citu Citu, Zhongming Zhao, Ignacio I Wistuba, Huamin Wang, Anirban Maitra, Yang Ch |
| Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521. JCO global oncology 2024 9 10 e2400125. Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Ya |
| Integrated molecular profiling of RAS, BRAF mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality. Journal of gastrointestinal oncology 2024 9 15 (4): 1580-1591. Gabriela Remonatto, Emily Ferreira Salles Pilar, Fernanda de-Paris, Pedro Guilherme Schaefer, Lúcia Maria Kliema |
| Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability. EMBO molecular medicine 2024 8 . Peiyong Guan, Jianfeng Chen, Chengqiang Mo, Tomoya Fukawa, Chao Zhang, Xiuyu Cai, Mei Li, Jing Han Hong, Jason Yongsheng Chan, Cedric Chuan Young Ng, Jing Yi Lee, Suet Far Wong, Wei Liu, Xian Zeng, Peili Wang, Rong Xiao, Vikneswari Rajasegaran, Swe Swe Myint, Abner Ming Sun Lim, Joe Poh Sheng Yeong, Puay Hoon Tan, Choon Kiat Ong, Tao Xu, Yiqing Du, Fan Bai, Xin Yao, Bin Tean Teh, Jing T |
| Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance. The Journal of clinical endocrinology and metabolism 2024 8 . Teresa Ramone, Arianna Ghirri, Alessandro Prete, Antonio Matrone, Raffaele Ciampi, Paolo Piaggi, Maria Scutari, Teresa Rago, Liborio Torregrossa, Cristina Romei, Rossella Elisei, Eleonora Molina |
| Genomic landscape of gallbladder cancer: insights from whole exome sequencing. International journal of surgery (London, England) 2024 8 . Supriya Awasthi, Rahul Kumar, Dibyabhaba Pradhan, Neetu Rawal, Harsh Goel, Parameswar Sahu, Sandeep Sisodiya, Rashmi Rana, Sunil Kumar, Nihar Ranjan Dash, Prasenjit Das, Usha Agrawal, G K Rath, Tanvir Kaur, R S Dhaliwal, Showket Hussain, Sundeep Singh Saluja, Pranay Tanw |
| Molecular characteristics of patients with colorectal signet-ring cell carcinoma with different ABO blood groups. Heliyon 2024 8 10 (13): e34220. Wan-Ning Zhang, Wei-Jie Liang, Ying Zhang, Ming-Jian Liang, Ming-Juan Zhang, Qi Chen, Zhou-Pei Mo, Mei-Yi Wu, Xue-Zi Weng, Rui Han, Yong-Neng Liang, Miao-La Ke, Wen-Qian L |
| Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell reports 2024 8 43 (8): 114616. Anne Huber, Amr H Allam, Christine Dijkstra, Stefan Thiem, Jennifer Huynh, Ashleigh R Poh, Joshua Konecnik, Saumya P Jacob, Rita Busuttil, Yang Liao, David Chisanga, Wei Shi, Mariah G Alorro, Stephen Forrow, Daniele V F Tauriello, Eduard Batlle, Alex Boussioutas, David S Williams, Michael Buchert, Matthias Ernst, Moritz F Eissma |
| Comprehensive analysis of gene mutations and mismatch repair in Chinese colorectal cancer patients. World journal of gastrointestinal oncology 2024 7 16 (6): 2673-2682. Huang Chen, Rui-Ying Jiang, Zhan Hua, Xiao-Wei Wang, Xiao-Li Shi, Ye Wang, Qian-Qian Feng, Jie Luo, Wu Ning, Yan-Fen Shi, Da-Kui Zhang, Bei Wang, Jian-Zheng Jie, Ding-Rong Zho |
| Inflammatory Giant Cell Carcinoma of the Lung: Clinicopathologic, Immunohistochemical, and Next-generation Sequencing Study of 14 Cases. The American journal of surgical pathology 2024 7 . David I Suster, A Craig Mackinnon, Natali Ronen, Haider A Mejbel, Shuko Harada, Michael Michal, Saul Sust |
| Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome. Hepatology international 2024 6 . Masanori Oshi, Kohei Chida, Arya Mariam Roy, Gabriella Kim Mann, Nan An, Li Yan, Itaru Endo, Kazuaki Taka |
| The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules. Hormones (Athens, Greece) 2024 6 . Lorenzo Scappaticcio, Nicole Di Martino, Paola Caruso, Pamela Ferrazzano, Federica Zito Marino, Eduardo Clery, Alessandro Cioce, Giovanni Cozzolino, Maria Ida Maiorino, Giovanni Docimo, Pierpaolo Trimboli, Renato Franco, Katherine Esposito, Giuseppe Bellastel |
| Prognostic Value of KRAS Mutations in Relation to PDL1 Expression and Immunotherapy Treatment in Adenocarcinoma and Squamous Cell Carcinoma Patients: A Greek Cohort Study. Journal of personalized medicine 2024 5 14 (5): . Theodora Tsiouda, Kalliopi Domvri, Efimia Boutsikou, Vasileios Bikos, Krystallia Kyrka, Konstantina Papadaki, Persefoni Pezirkianidou, Konstantinos Porpodis, Angeliki Che |
| Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations. Virchows Archiv : an international journal of pathology 2024 5 . Ben Davidson, Arild Holth, Kristina Lindemann, Ane Gerda Zahl Eriksson, Thale Andrea Nilsen, Annette Torgunr |
| The value of NGS-based multi-gene testing for differentiation of benign from malignant and risk stratification of thyroid nodules. Frontiers in oncology 2024 11 14 1414492. Mingjian Fei, Dongdong Ding, Xuanyi Ouyang, Wenyan Shen, Fenglan Zhang, Bo Zhang, Lan Q |
| Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment. European review for medical and pharmacological sciences 2024 11 28 (21): 4515-4525. Z Teke, A Bisgin, C Oruc Rencuzogullari, K Eren Erdogan, C K Parsak, S Kalkanli T |
| The tissue and circulating cell-free DNA-derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer. MedComm 2024 11 5 (12): e70011. Qingjian Chen, Yu-Hong Xu, Shiyang Kang, WuHao Lin, Linna Luo, Luping Yang, Qi-Hua Zhang, Pan Yang, Jia-Qian Huang, Xiaoni Zhang, Jing Zhang, Qi Zhao, Rui-Hua Xu, Hui-Yan L |
| Frequency of KRAS and BRAF mutations in colorectal carcinoma and their association with clinical-pathological characteristics in a tertiary hospital in Kenya. Frontiers in medicine 2024 10 11 1433120. Samuel Gakinya, Allan Njau, Abdulkarim Abdallah, Ancent Nzioka, James Ogu |
| Influence of recipient KRAS gene rs712 polymorphisms on the overall survival rate of hepatocellular carcinoma after hepatic transplantation. Clinical and experimental medicine 2024 10 24 (1): 246. Tiancheng Chu, Rulin Zhang, Xiaolei Liu, Li Lin, Yanning Li, Ziguang Niu, Heng Quan, Yingying Zhao, Yaohua |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
| Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. JAMA oncology 2024 10 . Maria E Cabanillas, Ramona Dadu, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan Fellman, Michelle D Williams, Mark Zafereo, Jennifer R Wang, Charles Lu, Matthew Ning, Brian A McKinley, Scott E Woodman, Dzifa Duose, Gary B Gunn, Naifa L Busaidy, |
| Early genetic divergence of high-grade carcinomas originating from low-grade ovarian serous neoplasms. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 10 100629. M Herman Chui, Qianqian Song, Jiarun Zhu, Yuchen Jiao, Brant Wang, Yeh Wang, Tian-Li Wang, Russell Vang, Ie-Ming Sh |
| Higher Inflammatory Response in Hepatocellular Carcinoma is Associated with Immune Cell Infiltration and a Better Outcome. Research square 2024 1 . Masanori Oshi, Kohei Chida, Arya Mariam Roy, Gabriella Kim Mann, Nan An, Li Yan, Itaru Endo, Kazuaki Taka |
| Clinicopathological and molecular characteristics of colorectal adenosquamous carcinoma in an Asian population. BMC gastroenterology 2024 1 24 (1): 36. Fujin Ye, Mian Chen, Xiaobin Zheng, Pinzhu Huang, Chao Wang, Huashan Liu, Hao Xie, Wei Xiao, Qin Guo, Liang Hua |
| Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Content source: